AZAD PHARMA LTD
Opportunity 71/100 (strong), bankability 70/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (76/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · accounting standard not declaredKey financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-03-31 | 2024-03-31 |
|---|---|---|
| Total assets | £20.3k | £11.0k |
| Cash | £60.0k | £60.9k |
| Net assets | £20.3k | £11.0k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
- • 1 confirmation-statement
- • 1 accounts
Corporate timeline (6 events)Click to expand
- 2025-12-19📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-08-20📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-12-01📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2022-03-09🏢Company incorporatedAs AZAD PHARMA LTD
- 2022-03-09➕ALI, Azad appointeddirector
- 2022-03-09📄incorporation-companyincorporation · NEWINC
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Sole director: Only one active director — all governance concentrated on one person.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Azad Ali Individual · British · DOB 12/1982 · age 44 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 09/03/2022 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · EH postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| AVODAH CARE LTD→ SC726265 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| BALLANTINE GOLDIE LTD→ SC392228 · est 2011 · no financials extracted | — | — | — | — | 15y | — | — |
| BEST HEARING LIMITED→ SC748989 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| BIRRELL AND RAINFORD OPTICIANS LIMITED→ SC383043 · est 2010 · no financials extracted | — | — | — | — | 15y | — | — |
| BLACKHILLS CLINIC LIMITED→ SC312434 · est 2006 · no financials extracted | — | — | — | — | 19y | — | — |
| BLAST BOXING CIC→ SC802686 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| BLETHER SOCIAL LIMITED→ SC836308 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| BLISS CARE SOLUTIONS LTD→ SC624411 · est 2019 · no financials extracted | — | — | — | — | 7y | — | — |
| BLND LTD→ SC761463 · est 2023 · no financials extracted | — | — | — | — | 3y | — | — |
| BLOSSOMING MINDS COUNSELLING LTD→ SC799877 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| BLUE DOOR DENTAL LIMITED→ SC442549 · est 2013 · no financials extracted | — | — | — | — | 13y | — | — |
| BLUE DOOR TOO LIMITED→ SC538855 · est 2016 · no financials extracted | — | — | — | — | 9y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.